News
MACE benefits with dapagliflozin improve with disease duration
March 4, 2020
Findings suggest treatment with the SGLT-2 inhibitor should be initiated early in some high-risk patients.
![1]()
News
AI algorithm finds diagnostic AFib signatures in normal ECGs
February 26, 2020
NATIONAL HARBOR, MD. – Machine learning created software that can reliably detect a signal of past or impending AFib in a normal-appearing ECG recording.
![1]()
News
When is a troponin elevation an acute myocardial infarction?
February 18, 2020
It is very important to classify the etiology of a troponin elevation and treat accordingly.
Article
ACC issues guidance on cardiac implications of coronavirus
February 14, 2020
The document provides information on the potential cardiac implications from analog viral respiratory pandemics and offers early clinical guidance given current COVID-19 uncertainty.
![1]()
News
Tools for preventing heart failure
February 13, 2020
SNOWMASS, COLO. – “There will be more than 1 million new cases of heart failure this year, and the vast majority of them could have been prevented.” – Gregg C. Fonarow, MD
![1]()
News
Medicare study evaluates impact of U.S. Hospital Readmissions Reduction Program
February 10, 2020
The proportion of care encounters studied that were preventable remains poorly understood.
![1]()
News
Cardiac arrest: Targeted temperature management a game changer
February 5, 2020
SNOWMASS, COLO. – “There are essentially no patients for whom temperature control somewhere in the range between 32 degrees C and 36 degrees C is contraindicated.”
![1]()
News
What 2019’s top five CAD trials tell us
January 29, 2020
SNOWMASS, COLO. – Triple therapy as a triple threat – a three-pronged threat to patient safety, Dr. Malcolm R. Bell says.
![1]()
News
Cardiac biomarkers refine antihypertensive drug initiation decisions
January 22, 2020
PHILADELPHIA – Analysis showcases a better way to select patients for intensive BP lowering.
![1]()
News
SPRINT-type BP control provides up to 3 years of additional life
January 14, 2020
PHILADELPHIA – Survival advantage of intensive over standard blood pressure lowering is age dependent.
